Benzinga | Aug 4, 2020 04:03PM EDT

Enanta Pharmaceuticals Q3 EPS $(0.71) Beats $(0.77) Estimate, Sales $18.65M Miss $27.89M Estimate

Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.77) by 7.79 percent. This is a 315.15 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $18.65 million which missed the analyst consensus estimate of $27.89 million by 33.12 percent. This is a 57.96 percent decrease over sales of $44.37 million the same period last year.